Overview
- 12 inspections across 12 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-01-23.
At a glance
Inspections
12
Sites
12
Observations
0
Career since
May 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fisher BioServices Inc | 23 Jan 2026 | Biologics | On file |
| Octapharma S.A.S. | 14 Nov 2025 | Biologics | On file |
| Clongen Laboratories LLC | 17 Jun 2025 | Biologics | On file |
| CAPRICOR INC | 30 May 2025 | Biologics | On file |
| Janssen Pharmaceuticals Inc. | 1 Nov 2024 | Biologics | On file |
Sites inspected
Fisher BioServices IncFrederick, United States1 insp.
Octapharma S.A.S.Lingolsheim, France1 insp.
Clongen Laboratories LLCGaithersburg, United States1 insp.
CAPRICOR INCSan Diego, United States1 insp.
Janssen Pharmaceuticals Inc.Raritan, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Gregory A Price3 shared
Ivey M Choi2 shared
Kevin J Matthews2 shared
Xiuju Lu2 shared
Jie He2 shared
Elena L Gubina2 shared
Wei Wang2 shared
Malcolm C Moos1 shared
Kyung E Sung1 shared
Svetlana A Shestopal1 shared
Full investigator report
Get the verbatim findings behind Carl A Perez's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site